Tilbake til søkeresultatene

PES-HORISONT-EU-PES Horisont Europa

FlowOx 3.0 NEURO

Tildelt: kr 74 999

Prosjektleder:

Prosjektnummer:

338405

Prosjektperiode:

2022 - 2023

Organisasjon:

FlowOx is an innovative non-invasive medical device that will disrupt decades of inadequate drug-based therapies with a novel approach to the medical practice and for the treatment of symptomatic pain and muscle spasms in MS patients. The mechanism of action will involve vascularly induced neuromodulation through sensory input which resets motor neuron control. The central nervous system is involved, and early studies show that neural reflexes are affected in the whole body. Preliminary results in MS patients indicated a reduction of +50% in spasticity (i.e., muscle spasms & rigidity) and a +40% pain. FlowOx will count on a patient support and motivation app, enabling real-time doctor-patient and patient-patient interactions and patient outcome reporting. FlowOx is the first connected home treatment device for MS spasticity and pain, addressing a major unmet clinical need. The goal of the PES application is to obtain EU funding through the EIC-accelerator program (H2020)

Budsjettformål:

PES-HORISONT-EU-PES Horisont Europa